Bruce Keyt, Chief Scientific Officer at IGM Biosciences, Inc. (IGMS), sold 2,500 shares at $96.00 ($240K) on 2021-02-03, disclosed to the SEC on 2021-02-04.
Open-market sale of $240k IGMS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $96.40 | 881 | $85K | 35.3% |
| 2 | $96.00 | 1,619 | $155K | 64.7% |
| Total | $96.14 avg | 2,500 | $240K | 100% |
| Filing → |
| IGMS | SELL | 2024-03-15 | $40K | — | Filing → |
| IGMS | SELL | 2023-12-15 | $44K | — | Filing → |
| IGMS | SELL | 2023-11-29 | $5K | — | Filing → |